Pacer Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.82M Sell
92,516
-34,978
-27% -$1.07M 0.01% 886
2025
Q1
$3.44M Sell
127,494
-464,507
-78% -$12.5M 0.01% 767
2024
Q4
$21.2M Buy
592,001
+47,745
+9% +$1.71M 0.05% 316
2024
Q3
$20.6M Buy
544,256
+76,904
+16% +$2.92M 0.04% 317
2024
Q2
$21.1M Buy
467,352
+58,597
+14% +$2.65M 0.05% 302
2024
Q1
$19.8M Buy
408,755
+71,384
+21% +$3.46M 0.05% 322
2023
Q4
$18.1M Buy
337,371
+145,373
+76% +$7.79M 0.05% 311
2023
Q3
$11.3M Buy
191,998
+59,736
+45% +$3.5M 0.04% 308
2023
Q2
$8.34M Sell
132,262
-3,071
-2% -$194K 0.03% 432
2023
Q1
$8.51M Buy
135,333
+37,214
+38% +$2.34M 0.04% 452
2022
Q4
$5.22M Buy
98,119
+33,496
+52% +$1.78M 0.03% 426
2022
Q3
$3.62M Sell
64,623
-747
-1% -$41.9K 0.03% 387
2022
Q2
$4.73M Buy
65,370
+16,084
+33% +$1.16M 0.04% 372
2022
Q1
$3.92M Buy
49,286
+9,522
+24% +$757K 0.03% 469
2021
Q4
$4.02M Buy
39,764
+8,603
+28% +$871K 0.04% 542
2021
Q3
$2.87M Buy
+31,161
New +$2.87M 0.04% 582
2021
Q2
Sell
-15,899
Closed -$1.55M 1560
2021
Q1
$1.55M Buy
15,899
+10,408
+190% +$1.02M 0.03% 595
2020
Q4
$423K Buy
5,491
+1,909
+53% +$147K 0.01% 1035
2020
Q3
$264K Buy
3,582
+937
+35% +$69.1K 0.01% 1143
2020
Q2
$194K Buy
2,645
+531
+25% +$38.9K ﹤0.01% 807
2020
Q1
$145K Sell
2,114
-2,450
-54% -$168K ﹤0.01% 466
2019
Q4
$359K Sell
4,564
-1,379
-23% -$108K 0.02% 858
2019
Q3
$406K Buy
+5,943
New +$406K 0.01% 1030